Literature DB >> 26261935

[Fecal microbiota transfer (FMT) in a patient with refractory irritable bowel syndrome].

Verena Zoller1, Anna-Lena Laguna1, Olivia Prazeres Da Costa2, Thorsten Buch2, Burkhard Göke1, Martin Storr1.   

Abstract

Irritable bowel syndrome is a disorder of the gastrointestinal tract with unknown etiology. Recent clinical data support a link between changes in fecal microbiota with decreased biodiversity and the development of irritable bowel syndrome. Whether these changes of the microbiota are caused by the disease or whether they develop during the course of the disease remains unclear. Several studies demonstrated that fecal microbiota transfer (FMT) successfully attenuates Clostridium difficile infection by restoring the disturbed bacterial flora of the gut and case reports suggest that FMT may relief symptoms in patients with irritable bowel syndrome (IBS). Here we report a 47-year-old male patient with longstanding refractory diarrhea predominant IBS, who was successfully treated with a single FMT. The beneficial effect on the patient's symptoms was associated with changes of the stool microbiome. Post-FMT the recipient's microbiome resembled the donor's microbiome. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26261935     DOI: 10.1055/s-0041-103798

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

Review 1.  16S rDNA analysis of the effect of fecal microbiota transplantation on pulmonary and intestinal flora.

Authors:  Tianhao Liu; Zhongshan Yang; Xiaomei Zhang; Niping Han; Jiali Yuan; Yu Cheng
Journal:  3 Biotech       Date:  2017-10-12       Impact factor: 2.406

Review 2.  The role of the microbiome in cancer development and therapy.

Authors:  Aadra P Bhatt; Matthew R Redinbo; Scott J Bultman
Journal:  CA Cancer J Clin       Date:  2017-05-08       Impact factor: 508.702

3.  The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.

Authors:  Tarek Mazzawi; Gülen Arslan Lied; Dag André Sangnes; Magdy El-Salhy; Johannes R Hov; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

4.  Patient perception and approval of faecal microbiota transplantation (FMT) as an alternative treatment option for obesity.

Authors:  F Gundling; S Roggenbrod; S Schleifer; M Sohn; W Schepp
Journal:  Obes Sci Pract       Date:  2018-11-28

Review 5.  Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.

Authors:  Duo-Chen Jin; Hai-Long Cao; Meng-Que Xu; Si-Nan Wang; Yu-Ming Wang; Fang Yan; Bang-Mao Wang
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.